"Most people would think that these organisms are just like spores or dormant," James Tiedje said. "These microbes are active ...

Aimed at addressing systemic inflammation, National Rosacea Society treatment algorithms take a phenotype-driven approach ...

Shihabeddin et al utilized single-cell RNA-Seq analysis of adult P23H zebrafish animals to identify transcription factors (e2fs, Prdm1a, Sp1) expressed selectively in neural progenitors and immature ...

Rein Therapeutics, Inc. , a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, ...

Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...

The girl was allegedly targeted by the principal who would regularly drop her to school; rare 'Touch DNA' used for first time ...

Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation ...

The AAAS selected five Penn professors from the School of Arts and Sciences, the Perelman School of Medicine, and the School ...

Early clinical results suggest the firm's antibodies targeting the Vβ T-cell receptor could induce strong and durable responses in cancer patients.

Two Vanderbilt faculty members have been elected 2024 fellows of the American Association for the Advancement of Science.

Mutations in BRCA2 — a gene known to repair damaged DNA and suppress tumor formation — can predict an individuals' predisposition to develop breast cancer, ovarian, prostate, pancreatic, and other ...

Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...